Dr. Vladimir Kakitelashvili, MD

Dr. Kakitelashvili practices at University of Maryland Community Medical Group, Inc. in Linthicum Heights, Maryland.

Dr. Kakitelashvili's NPI, 1700882297, was assigned on June 21, 2005. Dr. Kakitelashvili holds Maryland license D0057225.

Dr. Kakitelashvili's primary practice is University of Maryland Community Medical Group, Inc., at 900 Elkridge Landing Rd, Linthicum Heights, MD 21090 in Anne Arundel County. The practice phone is (443) 552-2900.

Dr. Kakitelashvili's primary practice is University of Maryland Community Medical Group, Inc. in Linthicum Heights, Maryland. Dr. Kakitelashvili is also affiliated with University of Maryland Charles Regional Medical Center. The medical group on file is UM Community Medical Group. Dmand AI also links Dr. Kakitelashvili to 1 more physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kakitelashvili practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kakitelashvili's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kakitelashvili is licensed in Maryland.

CMS data shows 2,260 Medicare services from Dr. Kakitelashvili across 15 procedure codes in 2024, for 691 Medicare patients. Medicare paid $123,379 for them.

CMS counts 691 Medicare patients who saw Dr. Kakitelashvili in 2024. The largest group is 75 to 84, with 295 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kakitelashvili's median patient age at 69, with 24% women.

In 2024, Dr. Kakitelashvili wrote 1,331 Medicare Part D claims for 350 patients. 93% of them were for generic drugs. CMS names the drug for 1,199 of them, across 20 drugs with 11 or more claims each, at $119,701 in total drug cost. In 2023, CMS named 831 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 27 out of 100 for Dr. Kakitelashvili for performance year 2024, reported individually. Dr. Kakitelashvili accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kakitelashvili as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 95 general payments to Dr. Kakitelashvili from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Astellas Pharma US Inc paid the most, $534.